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used above the wrist in our study because of inadequate calibration of veins 
and arteries; thus, we did not compare in “very” different regions. Among 
the complications, infections or other severe complications were not 
observed in both groups. This issue was described in detail in the study. 
The other question of the authors is about the patency that is in 
close relationship with the localization. PTFEs were used only between 
the brachial artery and high brachial vein. The reason for this selection 
was the diameter of the graft. Because thinner PTFEs are more likely to 
be thrombosed, the selected grafts were at least in 6 mm in diameter. 
The main finding of our study is the limited patency of the PTFE com-
pared with saphenous veins, although they were used in larger calibers 
and anastomosed between larger vessels.
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Cardiac enzyme (troponin levels) 
elevation in cardiac myxomas: Is it real?
To the Editor,
Constituting almost half of the cases of primary cardiac tumors (1), 
myxomas are frequently detected in adult female patients; moreover, 
familial patterns have also been identified for these tumors. The left 
atrium, right atrium, and ventricles are affected in 85%, 10%, and 5% of 
the cases, respectively. Furthermore, the fossa ovalis of the septum and 
the posterior atrial wall are common sites for the attachment of atrial 
myxomas (2). Interestingly, more than one myxoma or a polycentric 
myxoma can be detected in some patients (1, 2).
Atrial myxomas might be related to varied clinical presentations such 
as obstructive, constitutional, or embolic scenarios. Because of the block-
age of the atrioventricular valves, the obstruction pattern mimics mitral 
disease or, rarely, tricuspid valvular disease and can cause dyspnea or left 
heart failure; in such cases, it is sometimes difficult to differentially diag-
nosis myxomas from mitral or tricuspid valve stenosis (1, 3).
Although myxomas cause systemic embolism in about one-third of 
the patients, the incidence of coronary artery embolization has been 
reported to be 0.06-0.1% (3, 4). Although rare, the condition could be 
fatal. In a case series by Panos et al. (4), inferior, anterior, and posterior 
myocardial infarctions were diagnosed by electrocardiogram (ECG) in 
63.6%, 22.7%, and 9.1% of cases, respectively. Two possible explana-
tions have been suggested for the low incidence rate of coronary artery 
embolization by myxomas: the vertical position of the coronary ostia to 
the aortic blood flow and the coverage of the coronary ostia by the 
opening aortic valve leaflets during cardiac systole. Elevation of cardi-
ac troponin levels has also been reported in atrial myxomas, all of 
which were secondary to the coronary artery embolization (4, 5).
Interestingly, however, we examined 10 patients (age: 49±13 years; 
six females) with atrial myxoma and normal coronary arteries by angi-
ography and normal ECG but with elevation of cardiac enzymes. Cardiac 
troponin and CK-MB levels were measured on admission; these mark-
ers were elevated in six patients (four females; normal value of cardiac 
troponin: I=0.4 ng/mL; increased values in our six patients: 0.70, 1.10, 
2.35, 0.86, 1.67, and 1.45 ng/mL, respectively), all of whom had normal 
coronary arteries, based on angiography findings and normal ECG find-
ings, and had no accompanying chest pain. Patients were further 
investigated for exclusion of other reasons for elevated cardiac tropo-
nin levels, including renal failure, sepsis, pulmonary emboli, tachy, or 
bradyarrhythmias. These findings suggest that atrial myxoma increases 
cardiac markers without involvement of coronary arteries. Actually, we 
think such constitutional symptoms (fever, weight loss, or symptoms 
resembling connective tissue disease) are due to cytokine (interleu-
kin-6) secretion; cardiac markers could be secreted in cardiac myxo-
mas as well. Moreover, cardiac myxomas could be considered as the 
differential diagnosis for the diseases with elevated cardiac enzymes. 
However, further studies are required to reveal this association.
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The preanalytical and analytical 
factors responsible for false-positive 
cardiac troponins
To the Editor,
Cardiac troponins (cTn) are the cornerstone of the diagnosis, risk 
assessment, prognosis, and determination of antithrombotic and revas-
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